Climb Bio (CLYM) Treasury Shares (2020 - 2021)

Climb Bio (CLYM) has 7 years of Treasury Shares data on file, last reported at $207775.0 in Q1 2026.

• Quarterly Treasury Shares fell 77.13% year-over-year to $207775.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $207775.0 (down 77.13% YoY) and the FY2025 annual result came in at $207897.0, down 83.08% from the prior year.
• Treasury Shares held at $207775.0 in Q1 2026, from $207897.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.2 million in Q3 2024 to a low of $149975.0 in Q4 2023.
• A 5-year average of $461140.7 and a median of $219310.0 in 2022 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares sank 98.43% — and 2024, when it jumped 719.39%.
• Tracing CLYM's Treasury Shares over 5 years: stood at $177495.0 in 2022, then dropped by 15.5% to $149975.0 in 2023, then jumped by 719.39% to $1.2 million in 2024, then slumped by 83.08% to $207897.0 in 2025, then fell by 0.06% to $207775.0 in 2026.
• The last three Treasury Shares figures came in at $207775.0 (Q1 2026), $207897.0 (Q4 2025), and $207375.0 (Q3 2025), per Business Quant data.